BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33519937
Number of visits today
803
Number of downloads
16706310
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Deng S, Zhang L, Li J, Jin Y, Wang J. Activation of the PI3K-AKT signaling pathway by SPARC contributes to the malignant phenotype of cholangiocarcinoma cells. Tissue Cell 2022;76:101756. [PMID: 35217388 DOI: 10.1016/j.tice.2022.101756] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang S, Wu Y, Liu M, Zhao Q, Jian L. DHW-208, A Novel Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Has Anti-Hepatocellular Carcinoma Activity Through Promoting Apoptosis and Inhibiting Angiogenesis. Front Oncol 2022;12:955729. [DOI: 10.3389/fonc.2022.955729] [Reference Citation Analysis]
2 Wu W, Ling C, Lee M, Cheng C, Chen R, Lin C, You R, Chen Y. Targeting Src-Hic-5 Signal Cascade for Preventing Migration of Cholangiocarcinoma Cell HuCCT1. Biomedicines 2022;10:1022. [DOI: 10.3390/biomedicines10051022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345